ArticleNeurology(R) neuroimmunology & neuroinflammation2019

Tumefactive demyelination in a patient with relapsing-remitting MS on ocrelizumab.

Vanessa F Moreira Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.